Background Evidence linking female hormones to the development of mali
gnant melanoma has been contradictory. The purpose of this study was t
o examine the risk of melanoma in relation to exogenous and endogenous
hormonal variables in women, including oral contraceptives, replaceme
nt oestrogens, pregnancy, and menopause. Methods Hormonal and reproduc
tive factors were evaluated using data from a personal-interview popul
ation-based case-control study of melanoma in women conducted in Conne
cticut during 1987-1989. Caucasian female incident invasive melanoma c
ases (n = 308) were confirmed by standardized histopathological review
. Caucasian female controls (n = 233) were selected by random digit di
alling and frequency-matched on age. Data were analysed using multivar
iate logistic regression. Results Ever being pregnant, age at first pr
egnancy, current use of replacement oestrogens, ever use of oral contr
aceptives, duration of use of oral contraceptives, and age at first us
e of oral contraceptives were not associated with melanoma. Among othe
r variables, cases were more than twice as likely as controls to repor
t a single pregnancy lasting >6 months, but this association lacked a
dose-response relationship. Menopause and body mass index were not ind
ependently associated with risk of melanoma. However, this analysis di
d suggest that menopause and body mass index may be interactive risk f
actors. Melanoma cases were three times more likely than controls to b
e obese and report natural menopause when compared to thin/acceptable
premenopausal women (OR = 3.00, 95% CI: 1.03-8.73). Conclusions These
data do not provide strong evidence that hormonal and reproductive fac
tors are associated with risk of melanoma in women, although the few p
ositive results should be explored further.